Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Change in Acquisitions & Divestments (2018 - 2019)

Lifecore Biomedical, Inc. \De\ (LFCR) has 9 years of Change in Acquisitions & Divestments data on record, last reported at $68000.0 in Q4 2019.

  • For Q4 2019, Change in Acquisitions & Divestments fell 65.13% year-over-year to $68000.0; the TTM value through Aug 2020 reached $68000.0, down 91.91%, while the annual FY2020 figure was $364000.0, 33.21% down from the prior year.
  • Change in Acquisitions & Divestments reached $68000.0 in Q4 2019 per LFCR's latest filing, down from $296000.0 in the prior quarter.
  • Across five years, Change in Acquisitions & Divestments topped out at $4.4 million in Q1 2015 and bottomed at $68000.0 in Q4 2019.
  • Average Change in Acquisitions & Divestments over 4 years is $813625.0, with a median of $221000.0 recorded in 2016.
  • Peak YoY movement for Change in Acquisitions & Divestments: plummeted 94.66% in 2016, then tumbled 65.13% in 2019.
  • A 4-year view of Change in Acquisitions & Divestments shows it stood at $1.0 million in 2015, then crashed by 76.77% to $233000.0 in 2016, then decreased by 16.31% to $195000.0 in 2018, then crashed by 65.13% to $68000.0 in 2019.
  • Per Business Quant database, its latest 3 readings for Change in Acquisitions & Divestments were $68000.0 in Q4 2019, $296000.0 in Q3 2019, and $141000.0 in Q2 2019.